Literature DB >> 16951019

Should selective serotonin reuptake inhibitors be prescribed for children with major depressive and anxiety disorders?

Daniel J Safer1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16951019     DOI： 10.1542/peds.2006-0215

Source DB:  PubMed          Journal:  Pediatrics        ISSN： 0031-4005            Impact factor:   7.124


× No keyword cloud information.
  10 in total

1.  Short- and long-term functional consequences of fluoxetine exposure during adolescence in male rats.

Authors:  Sergio D Iñiguez; Brandon L Warren; Carlos A Bolaños-Guzmán
Journal:  Biol Psychiatry       Date:  2010-02-20       Impact factor: 13.382

2.  Juvenile administration of concomitant methylphenidate and fluoxetine alters behavioral reactivity to reward- and mood-related stimuli and disrupts ventral tegmental area gene expression in adulthood.

Authors:  Brandon L Warren; Sergio D Iñiguez; Lyonna F Alcantara; Katherine N Wright; Eric M Parise; Sarah K Weakley; Carlos A Bolaños-Guzmán
Journal:  J Neurosci       Date:  2011-07-13       Impact factor: 6.167

Review 3.  The pharmacological management of childhood anxiety disorders: a review.

Authors:  Shauna P Reinblatt; Mark A Riddle
Journal:  Psychopharmacology (Berl)       Date:  2007-01-05       Impact factor: 4.530

4.  Effects of psychotropic drugs on second messenger signaling and preference for nicotine in juvenile male mice.

Authors:  Lyonna F Alcantara; Brandon L Warren; Eric M Parise; Sergio D Iñiguez; Carlos A Bolaños-Guzmán
Journal:  Psychopharmacology (Berl)       Date:  2014-01-23       Impact factor: 4.530

5.  Repeated ketamine exposure induces an enduring resilient phenotype in adolescent and adult rats.

Authors:  Eric M Parise; Lyonna F Alcantara; Brandon L Warren; Katherine N Wright; Roey Hadad; Omar K Sial; Kyle G Kroeck; Sergio D Iñiguez; Carlos A Bolaños-Guzmán
Journal:  Biol Psychiatry       Date:  2013-06-19       Impact factor: 13.382

6.  Fluoxetine exposure during adolescence alters responses to aversive stimuli in adulthood.

Authors:  Sergio D Iñiguez; Lyonna F Alcantara; Brandon L Warren; Lace M Riggs; Eric M Parise; Vincent Vialou; Katherine N Wright; Genesis Dayrit; Steven J Nieto; Matthew B Wilkinson; Mary K Lobo; Rachael L Neve; Eric J Nestler; Carlos A Bolaños-Guzmán
Journal:  J Neurosci       Date:  2014-01-15       Impact factor: 6.167

7.  The pharmacoepidemiology of selective serotonin reuptake inhibitors for children and adolescents in Canada from 2005 to 2009: a database analysis.

Authors:  Darren Lam; Daniel A Gorman; Scott Patten; Tamara Pringsheim
Journal:  Paediatr Drugs       Date:  2013-08       Impact factor: 3.022

8.  Controversies concerning the diagnosis and treatment of bipolar disorder in children.

Authors:  Erik Parens; Josephine Johnston
Journal:  Child Adolesc Psychiatry Ment Health       Date:  2010-03-10       Impact factor: 3.033

Review 9.  Pharmacotherapy for anxiety disorders in children and adolescents.

Authors:  Ian Kodish; Carol Rockhill; Chris Varley
Journal:  Dialogues Clin Neurosci       Date:  2011       Impact factor: 5.986

Review 10.  Short- and Long-Term Antidepressant Clinical Trials for Major Depressive Disorder in Youth: Findings and Concerns.

Authors:  Daniel J Safer; Julie Magno Zito
Journal:  Front Psychiatry       Date:  2019-10-11       Impact factor: 4.157
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.